Promedigen Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$1.4M
- Investors
-
3
Promedigen General Information
Description
Operator of a biotechnology company intended to treat cancer and neurodegenerative disorders. The company specializes in providing customized modified protein technology that helps in the production of abnormally modified proteins that are associated with a variety of serious diseases, enabling doctors to treat cancer, dementia, and various other diseases effectively.
Contact Information
Website
www.promedigen.comCorporate Office
- Munji-ro, Yuseong-gu
- 113-115, Daejeon, Munji-dong
- Daejeon, 27216
- South Korea
Corporate Office
- Munji-ro, Yuseong-gu
- 113-115, Daejeon, Munji-dong
- Daejeon, 27216
- South Korea
Promedigen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series B) | 01-Dec-2024 | $1.4M | Completed | Pre-Clinical Trials | ||
| 1. Early Stage VC (Series A) | 01-Nov-2020 | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Promedigen Signals
Promedigen Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Sugentech | Corporation | Minority | ||
| Company K Partners | Venture Capital | Minority | ||
| DSC Investment | Venture Capital | Minority |
Promedigen FAQs
-
When was Promedigen founded?
Promedigen was founded in 2019.
-
Where is Promedigen headquartered?
Promedigen is headquartered in Daejeon, South Korea.
-
What is the size of Promedigen?
Promedigen has 12 total employees.
-
What industry is Promedigen in?
Promedigen’s primary industry is Drug Discovery.
-
Is Promedigen a private or public company?
Promedigen is a Private company.
-
What is Promedigen’s current revenue?
The current revenue for Promedigen is .
-
How much funding has Promedigen raised over time?
Promedigen has raised $1.4M.
-
Who are Promedigen’s investors?
Sugentech, Company K Partners, and DSC Investment have invested in Promedigen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process